RxDoctor Payments Data

Craig Osullivan, MD

Family Medicine · Gahanna, OHNPI 1083755169

Payments from drug & device makers

$277in general payments, 2019–2025

Across 16 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$75
  • Novo Nordisk$67
  • Medtronic$32
  • GSK$20
  • Amgen$20
  • AstraZeneca$17
  • plus $46 from 3 others

What the payments were for

  • Food & beverage$277100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie5$75
Novo Nordisk3$67
Medtronic2$32
GSK1$20
Amgen1$20
AstraZeneca1$17
Exact Sciences1$17
Lilly USA, LLC1$15
Pfizer1$14

How this compares

$277 in reported general payments places this provider in the 40th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$60,712
Medicare patients
244
Services billed
1,011

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide131$233,770
MounjaroTirzepatide81$108,711
EliquisApixaban86$82,679
JardianceEmpagliflozin46$65,988
TrulicityDulaglutide37$57,357
JanuviaSitagliptin Phosphate38$39,922
XareltoRivaroxaban20$32,585
Breo ElliptaFluticasone/Vilanterol20$13,617
GemtesaVibegron12$6,939
Rosuvastatin Calcium473$6,381
Atorvastatin Calcium514$4,450
Losartan Potassium448$3,810
SynthroidLevothyroxine Sodium101$3,605
Omeprazole254$3,147
Metoprolol Succinate229$3,146

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$67$233,770131 claims
Lilly USA, LLCMounjaro, Trulicity$15$166,068118 claims
PfizerEliquis$14$82,67986 claims
GSKBreo Ellipta$20$13,61720 claims
AbbVieSynthroid$75$3,605101 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Gahanna

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →